The chemistry of galactofuranose residue incorporation

ORGN 353

Laura L. Kiessling, Departments of Chemistry and Biochemistry, University of Wisconsin-Madison, 1101 University Avenue, Madison, WI 53706, Michelle Soltero-Higgin, msoltero@biochem.wisc.edu, Department of Biochemistry, University of Wisconsin - Madison, 433 Babcock Drive, Madison, WI 53706, Erin E. Carlson, carlsone@scripps.edu, Department of Chemistry, University of Wisconsin - Madison, Madison, WI 53706, John H. Phillips, jphillip@chem.wisc.edu, Department of Chemisty, University of Wisconsin - Madison, 1101 University Ave, Madison, WI 53706, John F. May, jmay@biochem.wisc.edu, Department of Biochemistry, University of Wisconsin, Madison, 433 Babcock Drive, Madison, WI 53706, and Todd D. Gruber, tdgruber@wisc.edu, Department of Biochemistry, University of Wisconsin-Madison, 433 Babcock Drive, Madison, WI 53706.

 

 

Tuberculosis (TB), the second leading cause of death worldwide, kills almost 2 million people annually. Agents that target Mycobacterium. tuberculosis, the causative agent of TB, are needed. A key component of the mycobacterial cell wall is the arabinogalactan polysaccharide, which contains galactofuranose residues (Figure). The essential flavoenzyme, uridine 5'-diphosphate (UDP)-galactopyranose mutase (UGM), generates a biosynthetic glycosyl donor required for arabinogalactan assembly. It catalyzes the interconversion of UDP-galactopyranose and UDP-galactofuranose. We synthesized UDP-galactofuranose and used this substrate to illuminate the mechanism of UGM. Our data suggest unprecedented reactivity for flavin cofactors. To discover UGM inhibitors, we developed a high throughput binding assay, and several leads have been identified. The chemistry and biology of galactofuranose residue incorporation and its relevance for inhibiting the process will be discussed.